Glycated Hemoglobin Testing Market to become Worth US$ 705 Mn by 2026

Document technical information

Format docx
Size 47.0 kB
First found Dec 12, 2017

Document content analysis

Category Also themed
Language
English
Type
not defined
Concepts
no text concepts found

Persons

Organizations

Places

Transcript

Glycated Hemoglobin Testing Market - Global Industry Analysis,
Size, Share, Growth, Trends and Forecast 2017 - 2026
Increasing incidences of diabetes have propelled the need for improved
diagnostics in the global healthcare devices. Companies manufacturing
critical diagnostic devices are focusing on facilitating products for effective
tests. The use of glycated hemoglobin in diagnosis of diabetes mellitus
continues to gain traction, creating a steady demand for glycated hemoglobin
testing. Transparency Market Research’s recent report on the global glycated
hemoglobin testing market delivers a forecast outlook on growing demand
for these tests in diagnosis of prevalent disorders such as diabetes.
According to the report, the global market for glycated hemoglobin testing is
expected to be worth US$ 705 Mn by the end of 2026. During the forecast
period, 2017-2026, the global glycated hemoglobin testing market is expected
to expand at a CAGR of 8.8%. Leading manufacturers of medical devices are
anticipated to be key participants in the global expansion of the glycated
hemoglobin testing market. Companies namely, Siemens Healthcare, BioRad Laboratories, Arkray, Ceragem Medisys, Bayer, Chek Diagnostics,
DiaSys Diagnostic Systems, Daiichi Biotech, Diazyme Laboratories, Erba
Mannheim, EKF Diagnostics, Human Diagnostics, Menarini, Lite-On
Technology, Mindray Medical, TaiDoc Technology, Sebia, Randox
Laboratories, Trinity Biotech, and Tosoh Bioscience are expected to be
observed as leading manufacturers of devices used in glycated hemoglobin
tests.
Browse Full Research Report:
https://www.transparencymarketresearch.com/glycated-hemoglobin-testingmarket.html
Key findings from the report reveal that the global market for glycated
hemoglobin testing will witness a significant traction in demand for
laboratory based tests. While patients are actively opting for point-of-care
glycated hemoglobin testing, laboratories continue to be the key medium
where these tests can be executed effectively. In 2017, more than US$ 240
Mn worth of revenues are anticipated to be procured in the global glycated
hemoglobin testing market from laboratory based tests. The study also
projects that by the end of 2026, point-of-care glycated hemoglobin tests will
account for over one-fourth revenue share of the global market.
A regional analysis on the global glycated hemoglobin testing market has
been provided in the report. Increasing presence of diabetics in the US and
Canada has been observed as the governing factors for fuelling the growth of
the glycated hemoglobin testing market in North America. In the overall
glycated hemoglobin testing market, North America is expected to dominate
in terms of global revenue share. In 2017, the glycated hemoglobin testing
market in North America is estimated to be worth over US$ 110 Mn.
Meanwhile, the demand for these tests is also expected to gain traction in
Europe and the Asia-Pacific excluding Japan (APEJ) region. Improving
healthcare infrastructure and diabetic dietary lifestyles of consumers in these
regions are observed as the superficial factors driving the growth of glycated
hemoglobin testing market in Europe and the APEJ region.
On the basis of techniques, glycated hemoglobin tests can be carried out
through immunoassays and chromatography, among others. In 2017, the sales
of devices in the global glycated hemoglobin testing market for
chromatography and immunoassay techniques are estimated to showcase
near-equal revenue share. Moreover, the use of these techniques will depend
largely upon the end-use of glycated hemoglobin tests. Hospitals are
anticipated to emerge as the largest end-users in the global glycated
hemoglobin testing market. In terms of revenues, the end-use of glycated
hemoglobin testing in hospitals is expected to rake in US$ 275 Mn globally
by the end of 2026. Diagnostic centers are also estimated to emerge as
leading end-users of glycated hemoglobin testing in the global market.
Browse Full Press Release:
Press Release
About Us
Transparency Market Research (TMR) is a global market intelligence
company providing business information reports and services. The
company’s exclusive blend of quantitative forecasting and trend analysis
provides forward-looking insight for thousands of decision makers. TMR’s
experienced team of analysts, researchers, and consultants use proprietary
data sources and various tools and techniques to gather and analyze
information.
TMR’s data repository is continuously updated and revised by a team of
research experts so that it always reflects the latest trends and information.
With extensive research and analysis capabilities, Transparency Market
Research employs rigorous primary and secondary research techniques to
develop distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com

Similar documents

×

Report this document